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IL-10 regulates the balance of an immune response between pathogen clearance and
immunopathology. We show here that Mycobacterium tuberculosis (Mtb) infection in the
absence of IL-10 (IL-10
/ mice) results in reduced bacterial loads in the lung. This
reduction was preceded by an accelerated and enhanced IFN-c response in the lung, an
increased inﬂux of CD4
1 T cells into the lung, and enhanced production of chemokines
and cytokines, including CXCL10 and IL-17, in both the lung and the serum. Neutraliza-
tion of IL-17 affected neither the enhanced production of CXCL10 nor the accumulation of
IFN-c-producing T cells in the lungs, but led to reduced numbers of granulocytes in the
lung and reduced bacterial loads in the spleens of Mtb-infected mice. This suggests that
IL-17 may contribute to dissemination of Mtb.
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Introduction
Tuberculosis (TB) is primarily a lung disease, and dissemination
of the pathogen depends on productive infection of this critical
organ [1–3]. A major role for CD4
1 T cells in protection against
Mycobacterium tuberculosis (Mtb) infection is well documented
[1–3]. To eradicate a pathogen such as Mtb, the host must mount
a protective response, which must be strictly regulated to limit
pathology while avoiding chronic infection.
A role for IL-12 and the Th1 cytokine IFN-g is established in
protection against mycobacterial infections in both mouse models
[4, 5] and human disease [6]. Early inﬂux of T cells producing
IFN-g has been demonstrated in Mtb resistant as compared with
more susceptible mouse strains [7]. Vaccination triggers an IL-17-
dependent accelerated IFN-g response by CD4
1 T cells in the lung
seen upon Mtb infection [8]. Although produced by CD4
1 [8] and
gd T cells [9] during Mtb infection, IL-17 has been shown to have
a limited role in host defense [10, 11]. TNF is critical for control
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mediated macrophage activation together with TNF is required in
the control of mycobacterial growth [4, 5, 12], at least in part by
the induction of nitric oxide [14], both cytokines being involved
in innate and adaptive immune protective responses to Mtb
infection.
Since IL-10 suppresses macrophage and DC functions,
including killing of intracellular pathogens and TNF and IL-12
production required for Th1 responses [15, 16], it is likely that
IL-10 induction during Mtb infection may affect the course of
disease. IL-10 may inhibit immunopathology as seen during
infections with intracellular pathogens [17, 18], or curb pathogen
clearance contributing to chronic infection [19–22]. In support of
a role for IL-10 in control of immune responses to mycobacterial
infection, IL-10mRNA is induced during experimental infection
with a number of mycobacterial species, including Mtb [23], and
has been correlated with enhanced disease in TB patients
[24–27]. Although IL-10-deﬁcient (IL-10
/) mice infected with
M. avium and M. bovis bacillus Calmette–Guerin [28–31] show
enhanced mycobacterial clearance, reports regarding a role for
IL-10 in limiting protection to Mtb infection have been conﬂicting
and inconclusive [23, 28, 32–35].
Upon aerosol infection with Mtb, the acquired cellular
response is slow to be induced in the lung. Mtb may infect diverse
types of phagocytic cells [36, 37]. The dissemination of myco-
bacteria from the lung to the draining LN (dLN) has been
suggested to involve lung DC [36–41], leading to the activation of
antigen-speciﬁc T cells and the induction of effector function
[42–44]. Although IL-12p40 promotes DC migration during
mycobacterial infection [41], IL-10 may limit it [39].
We show here that IL-10 does indeed control the immune
response to Mtb infection. Our ﬁndings show that infected
IL-10
/ mice maintain a reduced bacterial load in lungs with
decreased dissemination to the spleen, which is preceded by an
earlier and enhanced Th1-type response in the lung. In contrast,
IL-17 appeared to enhance dissemination to the spleen during
primary pulmonary Mtb infection.
Results
Enhanced control of Mtb infection in IL-10
/ mice
To explore a potential role of IL-10 in the control of the immune
response to Mtb H37Rv, we ﬁrst investigated the expression of
this cytokine in the lungs of mice upon aerogenic infection. The
expression of IL-10 mRNA (Fig. 1A) and IL-10 protein (Fig. 1B)
was induced following Mtb infection in the lungs of BALB/c and
C57BL/6 in accordance with the previous reports [23]. IL-10
/
mice showed a signiﬁcant and prolonged tenfold reduction in
bacterial load in lungs and spleen from day 28 postinfection until
the end of the study, as compared with WT control mice (Fig. 1C
and D). These effects were not restricted to mice on the BALB/c
background, as the absence of IL-10 in mice on C57BL/6
background (Fig. 1E and F), or neutralization of its signalling
capacity by mAb in CBA/J mice (Fig. 1G), signiﬁcantly reduced
bacterial burdens in the lungs and spleen at the time points
investigated, as reported previously [34].
Enhanced and accelerated Th1 responses in lungs of
infected IL-10
/ mice
To determine whether enhanced protection against Mtb infection
reﬂected an accelerated and/or enhanced immune response to
the pathogen, cell suspensions from lungs, dLN and spleens were
analysed. An increase in the numbers of CD4
1 T cells (Fig. 2A)
was observed in the lungs and dLN of IL-10
/ mice at day 29
after infection with Mtb as compared with controls. This increase
in CD4
1 T-cell numbers was not observed in spleens from
infected IL-10
/ mice (Fig. 2B). Furthermore, increased
percentages of IFN-g
1 CD4
1 T cells were observed in lungs of
IL-10
/ mice infected with Mtb at all time points after infection,
with the most striking difference apparent at day 29 (0.91%, WT
to 4.83%, IL-10
/ mice: Supporting Information Fig. 1B). In
contrast, increased percentages of IFN-g-producing CD4
1 T cells
in IL-10
/ mice were not observed in the dLN or minimally
enhanced in the spleen but only much later after infection as
compared with WT mice. The increased numbers of CD4
1 T cells
(Fig. 2A) and percentages of CD4
1 IFN-g-producing T cells were
observed early in the lung after Mtb infection of IL-10
/ mice,
translated to highly signiﬁcant increases in the numbers of Th1
cells (Fig. 2B). Collectively, these data suggest that IL-10
/ mice
show signiﬁcant and sustained Mtb control, which correlated
with an accelerated and enhanced expansion of CD4
1 T cells in
the dLN, together with increased differentiation, expansion and
migration of Th1 cells to infected lungs (Fig. 2B).
To further investigate the local immune response to Mtb
infection, lung cell suspensions were restimulated with puriﬁed
protein derivative (PPD) and cytokine/chemokine production
was evaluated in supernatants, initially performing a primary
screen on 22 analytes, using a multiplex cytokine assay
(Fig. 3 and Supporting Information Table 1) at a chosen time
point (day 28) based on the preliminary data. In keeping with the
enhanced numbers of Th1 cells in the lungs of infected IL-10
/
mice (Fig. 2B), the levels of IFN-g were signiﬁcantly elevated
early after Mtb infection in supernatants from IL-10
/ restimu-
lated lung suspensions (Fig. 3). This was accompanied by
increased levels of CXCL10 (IP-10), TNF, IL-17A, IL-6, G-CSF, and
to a lesser extent GM-CSF, which all peaked at day 22 post-
infection (Fig. 3). Increases in IL-1a, IL-1b, IL-2 and CCL3 were
seen upon infection with Mtb and elevated to a small extent in
supernatants from infected IL-10
/ mice versus controls; little to
no change was seen in supernatants of IL-12p70, IL-4, IL-5, IL-7,
IL-9 and IL-13 upon Mtb infection and no difference between WT
and IL-10
/ mice – any small differences were variable
(Supporting Information Table 1). Differences between WT and
IL-10
/ mice were not observed for CXCL10, TNF, IL-6
and G-CSF by day 56 postinfection. In contrast, elevated levels
of IFN-g, IL-17A and GM-CSF were still apparent at day 56
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hypothesis, using the multiplex assay, similar trends in IFN-g,
CXCL10, TNF, IL-17A, IL-6 and G-CSF only were also observed in
sera from IL-10
/ mice albeit at much lower levels (Fig. 4;
Supporting Information Table 2). In accordance with our ﬁndings
in the lung (Fig. 3), each cytokine/chemokine in the serum of
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Figure 1. IL-10 limits bacterial clearance following aerosol infection with Mtb. (A) Il10 mRNA expression (RT-PCR) and (B) IL-10 protein (ELISA)
following ex vivo restimulation with PPD of lung cell homogenates prepared from aerogenically Mtb-infected BALB/c and C57BL/6 mice. (C, D) WT
BALB/c and BALB/c IL-10
/ mice were killed at the time points indicated postinfection and bacterial burdens were determined in the (C) lungs and
(D) spleen. The BALB/c data shown here are combined from six independent experiments. (E, F) Bacterial burdens in the lungs and spleens of WT
(open bars) and IL-10
/ (closed bars) C57BL/6 mice were determined at the time points indicated. Data from C57BL/6 mice are (E) combined from
two independent experiments (n511–15 mice per group) and (F) from one independent experiment (n57 mice per group). (G) CBA/J mice were
treated before and during Mtb infection with anti-IL-10R mAb (or control IgG) and bacterial burdens determined at day 103 postinfection (data are
from one independent experiment, n55–6 mice per group). (Data are mean7SEM). p o 0.05; p o 0.01; p o 0.001 (unpaired Student’s t-test); ND, not
done; o, below detection limit of the assay.
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/ mice peaked at around 21 days after infection,
suggesting that elevated levels in the sera resulted from spill-over
of the immune response to the pathogen in the infected lung.
Thus the capacity of IL-10
/ mice to respond to Mtb infection
with increased and earlier production of IFN-g, CXCL10, IL-17A,
IL-6, G-CSF and GM-CSF in the lung (Fig. 3) and serum (Fig. 4)
correlates with a subsequent, pronounced and long-lasting
signiﬁcant decrease in bacterial load (Fig. 1C and D).
Th1 responses in lungs of Mtb infected IL-10
/ mice
are IL-17 independent
Our data suggest that the enhanced differentiation
and early inﬂux of Th1 cells producing IFN-g into the lungs of
IL-10
/ mice infected with Mtb results in the subsequently
enhanced bacterial clearance. The elevated levels of IL-17A
(Fig. 3) and IL-17A-producing cells (Supporting Information
Fig. 2A–D) that we also observe in the lungs of infected IL-10
/
mice could account for the enhanced production of the
chemokine CXCL10 (Fig. 3) and the early inﬂux of Th1
effector cells into the lung (Fig. 2B), as previously reported
following vaccination [8]. Alternatively, deﬁciency of IL-10
in our system could bypass the requirement for IL-17A and
CXCL10 production and enhanced Th1 inﬂux into the
lung, resulting in subsequent protection against Mtb. To test
this, IL-17 was neutralized in mice via use of a mAb before and
during infection with Mtb, and effects on IFN-g and CXCL10
production and cellular inﬂux into the lung were examined. The
enhanced cellular inﬂux, including that of CD4
1 and CD8
1
T cells, observed in Mtb infected IL-10
/ mice as compared with
WT control mice was unaffected by neutralization of IL-17
(Fig. 5A–C). Furthermore, the increased numbers of IFN-g-
producing CD4
1 and CD8
1 T cells (Fig. 5D and E), and the
increased amounts of IFN-g and CXCL10 seen in supernatants of
stimulated lung cells (Fig. 5F and G), or in serum (Fig. 5H and I)
or in infected IL-10
/ mice were not signiﬁcantly affected
following IL-17 neutralization. Hence, our ﬁndings suggest that,
in contrast to vaccination [8], an absence of IL-10 can enhance
and accelerate Th1 responses in the lung during primary Mtb
infection independently of IL-17.
Effects of neutralizing IL-17 during primary Mtb
infection
It has been shown [45] (and reviewed in [11]) that IL-17
signalling is critical for granulocyte mobilization to the lung
during Klebsiella pneumoniae infection. Similarly, following IL-17
neutralization, we observed a signiﬁcant decrease in total
numbers of lung GR-1
1CD11b
1 granulocytes in IL-17 Ab treated
as compared with isotype control IgG-treated WT and IL-10
/
mice post-Mtb infection (Fig. 6A). Neutralization of IL-17 had no
signiﬁcant effects on IFN-g or CXCL10 production in the lung or
serum, or on T-cell inﬂux in Mtb-infected IL-10
/ mice.
Neutralization of IL-17 during primary Mtb infection in either
WT or IL-10
/ mice had no signiﬁcant effect on bacterial load in
the lungs at this early time point (Fig. 6B). IL-17 neutralization
during primary Mtb infection of WT mice, and to a lesser extent
IL-10
/ mice, resulted in a decreased bacterial load in the spleen
(Fig. 6C). The lesser effect observed in IL-10
/ mice is possibly
due to the higher levels of IL-17, although the bacterial load was
lower to start with in the IL-10
/ mice. These observations
suggest that IL-17 may have adverse effects and potentially
impair the host’s ability to control Mtb infection at secondary
disease sites.
Figure 2. Earlier and enhanced accumulation of CD4
1 T cell and cytokine-producing CD4
1IFNg
1 cells in the lungs of infected IL-10
/ as compared
with WT mice. (A) The total number of CD4
1CD3
1 T cells present in the indicated organs of WT (open bars) and IL-10
/ (closed bars) BALB/c mice
infected with Mtb was determined by ﬂow cytometry and calculated based on the total cell counts acquired at each time point for each individual
mouse. The percentage of CD4
1IFNg
1 T cells (Supporting Information Fig. 1B) and total numbers of CD4
1IFNg
1 cells (B) were determined following
restimulation of whole organ homogenates ex vivo. Cells were stained with the appropriate Ab and CD4
1IFNg
1 levels determined by ﬂow
cytometry according to the gating strategy shown in Supporting Information Fig. 1A. Data are mean7SEM and are representative of at least two
independent experiments (n53–4 mice per group). p o 0.05 (unpaired Student’s t-test); ND, not done.
Eur. J. Immunol. 2010. 40: 2200–2210 Immunity to infection 2203
& 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.euDiscussion
We provide evidence that IL-10
/ mice show enhanced control
of Mtb infection with signiﬁcantly reduced bacterial load in lungs
and spleen, which was maintained over the course of infection
studied. Increased protection in IL-10
/ mice was associated
with an accelerated and enhanced Th1 response in the lung.
Earlier and increased levels of the cytokines/chemokines, IFN-g,
TNF, CXCL10, IL-6 and IL-17 were detected in sera and lungs of
infected IL-10
/ mice as compared with WT control mice,
coincident with the increased and earlier inﬂux of CD4
1 T cells
into the lungs. The earlier and enhanced production of CXCL10
and the accelerated inﬂux of Th1 cells into the lung of infected
IL-10
/ mice was independent of IL-17. Instead, neutralization
of IL-17 during primary Mtb infection resulted in a signiﬁcant
decrease in bacterial load in the spleen, suggesting a potential
role for IL-17 in dissemination of mycobacteria.
Previous reports have suggested that IL-10
/ and WT mice
display identical capacity to control Mtb infection [23, 33],
whereas others have reported enhanced early although transient
protection to this pathogen in IL-10
/ mice with enhanced IFN-g
production in the dLN [28]. Our novel ﬁndings are distinct since
we show that IL-10
/ mice maintain a reduced bacterial load in
the lung and spleen during Mtb infection, which was independent
of the genetic background studied. These conﬂicting reports in
the literature may be due to differences in the ages of mice, the
initial dose of infecting bacteria and/or the microbial ﬂora/status
of mice in different laboratories. The enhanced protection that
we observe in IL-10
/ mice infected with Mtb not only correlates
with early and increased responses of CD4
1 T cells in the dLN but
also with accelerated and elevated production of the chemokine
CXCL10 and increased numbers of Th1 cells in the lung.
There are various potential mechanisms whereby IL-10 could
suppress the immune response to Mtb infection, leading to
reduced protection and increased bacterial burden. There is
compelling evidence that the initiation of the response to Mtb
occurs in the LN [42–44]. Hence, IL-10 could function to suppress
the production of cytokines/chemokines required for the migra-
tion of infected myeloid cells to the LN and thus inhibiting the
initiation of a protective immune response. This is suggested by
Figure 3. Following Mtb infection, IL-10
/ mice have an earlier and enhanced production of proinﬂammatory cytokines in the lungs as compared
with WT mice. Lung tissue from Mtb-infected WT (open bars) and IL-10
/ BALB/c (closed bars) mice was isolated, homogenized and restimulated
with PPD after which supernatants were removed and screened by Multiplex assay for the indicated cytokines (see also Supporting Information
Table 1). Data are mean7SEM and are representative of at least two independent experiments (n53–4 mice per group). p o 0.05; p o 0.01;
p o 0.001 (unpaired Student’s t-test); ND, not done; o, below detection limit of the assay.
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ted DC from IL-10
/ mice show increased trafﬁcking to the dLN
in response to mycobacterial antigens, although the effects on
bacterial load were not assessed [39]. In keeping with these
ﬁndings, we observe an increased number of CD4
1 T cells in the
dLN of IL-10
/ mice as compared with controls, although the
percentages of IFN-g-producing CD4
1 T cells were equivalent.
However, we show markedly increased percentages and numbers
of IFN-g-producing CD4
1 T cells in the lungs of infected IL-10
/
mice as compared with control mice in keeping with increased
Th1 differentiation and inﬂux into the lungs. Taken together, our
data suggest that the increased numbers of IFN-g-producing cells
in the lungs result from a combination of increased activation/
proliferation in the dLN, and increased migration/differentiation
to the lung. In all, our ﬁndings suggest that the major effects of
IL-10 to suppress the immune response to Mtb are in the lung and
dLN, and that by neutralizing this cytokine an earlier local Th1
response in the lung can dictate the subsequent level of protec-
tion observed up to 125 days of infection. This is in keeping with
the previously reported ﬁndings that enhanced protection
to Mtb infection in relatively resistant as compared with suscep-
tible mice is paralleled by an earlier inﬂux of T cells producing
IFN-g [7].
The enhanced and early production of CXCL10 that we observe
in Mtb-infected IL-10
/ mice may contribute to the increased
number of IFN-g-producing CD4
1 T cells recruited to the lungs, in
keeping with the known role of CXCL10 in Th1 migration during
other infections [46]. Thus far, we ﬁnd no apparent enhanced
Figure 4. IL-10
/ mice have enhanced levels of proinﬂammatory mediators in the serum, following Mtb infection as compared with WT mice. WT
BALB/c (open bars) and IL-10
/ (closed bars) BALB/c mice were infected with Mtb. At speciﬁc time points, postexposure groups of mice were killed,
serum was obtained from the coagulated blood samples and screened by a multiplex cytokine proﬁler assay (Supporting Information Table 2). The
data are mean7SEM and are representative of two independent experiments (n53–5 mice per group). p o 0.05; p o 0.01 (unpaired Student’s t-test).
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/
mice as compared with those from WT mice (data not shown).
However, it is possible that IL-10 produced by other cells during
infection suppresses the production or action of microbicidal
factors induced in macrophages important for protection against
Mtb infection. Enhanced and earlier IFN-g production, together
with the increased levels of TNF, that we observed in the lungs of
Mtb-infected IL-10
/ mice will undoubtedly result in the
enhanced activation of macrophages for control of mycobacterial
growth, in keeping with the reported properties of these cytokines
in the protective response to mycobacterial infection [4, 5, 12].
Elevated levels of GM-CSF in the lung of Mtb-infected IL-10
/
mice as compared with controls could also contribute to the
enhanced protection observed, since GM-CSF has been previously
shown to be important for recruitment of Th1 cells to the lung and
containment of Mtb [47].
IL-17 has been shown to be important for the increased
inﬂux of Th1 cells into the lungs, after vaccination against Mtb
infection [8]. However, we show that neutralization of IL-17
during primary Mtb infection had no effect on the enhancement
of IFN-g or CXCL-10 production in the serum or lungs,
nor the accelerated and enhanced numbers of Th1 cells
in the lungs of IL-10
/ mice. In keeping with a previous
report where IL-17R-deﬁcient mice showed no effects on Mtb
infection [10, 11], in our study neutralization of IL-17 in
either WT or IL-10
/ mice showed no effect in controlling Mtb
infection in the lung, although this was a relatively early time
point. However, and quite unexpectedly, neutralization
of IL-17 in WT and IL-10
/ mice, resulted in a reduction in Mtb
load in the spleen, which suggests that IL-17 may affect disse-
mination of mycobacteria to the spleen during an aerogenic
infection. In line with this, total lung granulocyte numbers were
Figure 5. The enhanced cellular inﬂux and IFN-g production seen in IL-10
/ mice during Mtb infection are not IL-17 dependent. WT (open bars)
and IL-10
/ (closed bars) BALB/c mice were infected with Mtb and treated twice weekly with either anti-IL-17 mAb or isotype IgG. Mice were killed
on day 32 postinfection and the lungs isolated. (A) Total lung cell counts, (B) total CD4
1 T cells and (C) total CD8
1 T cells following IL-17
neutralization were determined by ﬂow cytometry staining for CD3, CD4 and CD8. Whole lung homogenates from anti-IL-17-treated and isotype
control-treated mice were restimulated with PPD and the total number of (D) CD4
1IFN-g
1 and (E) CD8
1IFN-g
1 cells in the lungs of infected WTand
IL-10
/ BALBc mice was determined by ﬂow cytometric analysis. Cell culture supernatants of the restimulated lung homogenates were analysed
for (F) IFN-g and (G) CXCL10. Serum levels of (H) IFN-g and (I) CXCL10 from Mtb-infected Ab-treated mice were assayed as described in Fig. 4. Results
(mean7SEM) shown are combined data from two independent experiments, totalling ten mice per group (A–E) or three to six mice per group (F–I).
NS, nonsigniﬁcant (unpaired Student’s t-test).
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/ anti-IL-17-
treated mice as compared with isotype-treated control mice,
suggesting that IL-17 through its role in granulocyte recruitment
may facilitate bacterial dissemination from the lung to
secondary disease sites. To support this, although dissemination
of mycobacteria to dLN has been suggested to be mediated
by DC [36–41], phagocytic cells of diverse phenotypes,
including neutrophils have been shown to be infected with
mycobacteria [38, 48, 49], suggesting a role for these cells as
permissive hosts. Although it has been suggested that granulo-
cytes may play a role in granuloma formation in relatively
resistant mice [50], many reports support a negative role for
neutrophils/granulocytes in TB pathogenesis in genetically
susceptible mouse strains [51, 52] and in active TB patients
[53, 54]. During Mtb infection, neutrophils have recently been
shown to be the dominant producers of IL-10 in the lung and
depletion of these cells [55] reduced lung bacterial load while
enhancing IL-6 and IL-17 but not IFN-g responses. Collectively,
these reports suggest a detrimental role for neutrophils in
pathogenesis of TB.
In conclusion, we show here that IL-10 controls the primary
immune response to Mtb infection, and that in the absence of this
cytokine, mice maintain a reduced bacterial load and an accel-
erated and earlier Th1-type response in the lung with reduced
dissemination to the spleen. Thus, it is tempting to speculate that
neutralization of IL-10 during vaccination may lead to an accel-
erated, enhanced and nonpathological protective Th1 response
against Mtb infection.
Materials and methods
Mice
Female BALB/c, BALB/c IL-10
/, C57BL/6 and C57BL/6
IL-10
/ were bred and housed under speciﬁc pathogen-free
conditions at the MRC NIMR. CBA/J mice were purchased from
Charles River, France. Experiments were in accordance with the
Home Ofﬁce (UK). Mice were 8–14wk of age.
Mtb infection
Mtb experiments were performed under Containment level-3
conditions. Mtb H37Rv was grown in Middlebrook 7H9 broth
supplemented with 10% OADC (Difco), 0.05% Tween-80, 0.5%
glycerol to mid-log phase before freezing at 801C. For aerogenic
infections, a three-jet Collision nebulizer unit (BGI, USA) was used.
Brieﬂy, 110
7CFU Mtb in PBS were aerosolized over a period of
15min with approximately 30CFU delivered to the lungs as
conﬁrmed by enumeration of bacteria on day 1 postinfection.
In vivo Ab treatment
Mice were injected i.p. with 100mg of mAb against IL-17
(R & D systems; 50104) or an isotype control IgG (R & D
Figure 6. The presence of IL-17 during Mtb infection in mice has adverse effects on bacterial dissemination to secondary disease sites. WT (open
bars) and IL-10
/ BALB/c (closed bars) mice were treated with anti-IL-17 Ab (or isotype control IgG) before and during infection with Mtb. Mice
were killed on day 32 postinfection and the lungs were isolated, homogenized and analysed by ﬂow cytometry on the basis of (A) GR1, CD11b
expression and high side scatter in order to determine the effect of IL-17 neutralization on granulocyte levels in the lungs. Bacterial burdens were
determined in the (B) lungs and (C) spleen of anti-IL-17- or isotype control-treated mice. Results are mean7SEM and are combined from two
independent experiments, totalling ten mice per group except for the WTisotype-treated group in (C) where n56 mice per group. p o 0.05; p o 0.01;
p o 0.001 (unpaired Student’s t-test).
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infection (day 0), every 3–4 days until day 28, and killed at day
32 postinfection. In total, 1mg anti-IL-10R mAb (a kind gift from
DNAX, now Merck, Palo Alto, CA, USA; 1B1.3A) or isotype
control IgG (Merck; GL113) was injected i.p. in PBS the day
before infection and then 0.35mg was given once weekly
thereafter until the end of the experiment.
Removal of organs for cell culture and determination of
bacterial load
Spleens and lungs were aseptically removed from mice (killed by
CO2 exposure) and homogenized by passing through a 70mm sieve
in cRPMI for immune function. Cell pellets were treated with 0.83%
ammonium chloride, placed in culture medium, counted and
restimulated ex vivo with either Tuberculin PPD for 48h (10mg/
mL; Statens Serum Institut) or with PMA (50ng/mL; Sigma-Aldrich)
and ionomycin (500ng/mL; Calbiochem) for 4h. For intracellular
IFN-g or IL-17A analysis by ﬂow cytometry, brefeldin A (10mg/mL;
Sigma-Aldrich) was added during the last 4h of cell cultures. Cell
suspensions were serially diluted onto 7H11 agar plates supple-
mented with OADC (10%) and after 18 days at 371C, visible CFU
were counted and the bacterial load per organ was calculated.
Flow cytometry
For the analysis of cell surface markers, cells were pretreated for
10min with anti-FcgRI/FcgRII (anti-CD16/CD32) to minimize a
speciﬁc Ab binding. Staining was performed in Dulbecco’s PBS
(Gibco) supplemented with 1% FBS, penicillin (100U/mL),
streptomycin (100mg/mL) and 0.1% sodium azide (Sigma-
Aldrich). The markers CD3-APC (BD; 145-2C11), CD4-PerCP
(BD; RM4-5), CD8-FITC (eBioscience; 53-6.7) and gd TCR-PE
(eBioscience; eBioGL3) were used to identify T-cell populations.
Lung granulocytes were identiﬁed by the expression of GR-1-FITC
(BD; RB6-8C5) and CD11b-APC (BD; M1/70) and the absence of
CD11c-PE (BD; HL3) and CD4-PerCP (BD; RM4-5) and by high
side scatter. Cells were stained for 30min, washed and ﬁxed in 2%
formaldehyde (Sigma-Aldrich) before acquisition. For intracellular
cytokine analysis, cells were ﬁxed and treated with permeabiliza-
tion buffer (eBioscience) according to the manufacturer’s instruc-
tions and stained with IFN-g-APC (BD; XMG1.2) and IL-17A-PE
(BD; TC11-18H10) and relevantly conjugated isotype control Ab.
Acquisition was performed with CellQuest software on a FACS
Caliber ﬂow cytometer (BD Biosciences) with a minimum of at
least 100000 total events being collected. The data were analysed
using FlowJo version 8 (Treestar) software.
Immunoassay/multiplex assay
Protein analysis of mouse sera and cell culture supernatants
obtained from ex vivo restimulations was screened commercially
by a ‘‘22-Multiplex cytokine proﬁler’’ assay for G-CSF, GM-CSF,
IL-1a, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12(p70),
IL-13, IL-15, IL-17A, IFN-g, TNF, CCL2 (MCP-1), CCL3 (MIP-1a),
CCL5 (RANTES), CXCL1 (KC/Gro) and CXCL10 (IP-10) (Milli-
pore, UK). Commercially available ELISA kits (eBioscience) were
also used to determine the concentrations of IL-17A, GM-CSF and
TNF in sample supernatants. ELISA assays were performed
according to the manufacturer’s protocol.
Real-time PCR of Il10 expression in lung tissue
Whole lung tissue was aseptically removed and homogenized
immediately in TRI-reagent (Ambion) RNA buffer by pulsing with
a Polytron PT1600E homogenizing unit (Kinematic) before being
frozen at 801C. For RNA extraction, the samples were thawed
and an RNeasy kit (Qiagen) was used according to the
manufacturer’s protocol. RNA was reverse transcribed with a
high-capacity reverse transcription kit (Applied Biosystems) to
cDNA and run on an ABI PRISM 7900 sequence-detection system
(Applied Biosystems). Murine Il10 primers were used as
described previously [56] and mRNA expression was quantiﬁed
with SYBR Green (Applied Biosystems). Expression data shown
for Il10 were normalized to Hprt1.
Statistical analysis
All data were analysed as indicated in the ﬁgure legends using
Student’s t-test (95% conﬁdence interval) with differences being
considered signiﬁcant when po0.05 (po0.05; po0.01;
po0.001).
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